DPZ-Homepage
Menu mobile menu

Platform Degenerative Diseases

Cycle

Two different types of pluripotent stem cells are in the focus of the platform Degenerative Diseases (formerly Stem Cell Biology Unit): induced pluripotent stem cells (iPS cells) and embryonic stem cells (ES cells). Pluripotent stem cells could become important in the future regarding novel therapeutic approaches to the treatment of serious human diseases. In addition, we are interested in primate germ cell development and aspects of early embryonic development.

Hence, our work has (pre-) clinical relevance as well as basic cell biological and developmental aspects. However, it is important to note that understanding of basic biological mechanisms is a precondition to develop new therapeutic strategies.

(c) DPZ
Common marmoset monkey (Callithrix jacchus)
(c) DPZ
Two colonies of common marmoset monkey embryonic stem cells.

               

Prof. Dr. Rüdiger Behr Head of Platform Degenerative Diseases +49 551 3851 132 +49 551 3851 431 Contact

Kerstin Zaft Secretary +49 551 3851 402 +49 551 3851 431 Contact